- Home
- AR vs RGC Comparison
AR vs RGC Comparison
Compare AR & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AR | RGC |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 9.8B |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AR | RGC |
|---|---|---|
| Price | $34.27 | $31.74 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $44.33 | N/A |
| AVG Volume (30 Days) | ★ 5.7M | 971.7K |
| Earning Date | 02-11-2026 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.87 | N/A |
| Revenue | ★ $5,007,754,000.00 | N/A |
| Revenue This Year | $24.32 | N/A |
| Revenue Next Year | $20.34 | N/A |
| P/E Ratio | $18.35 | ★ N/A |
| Revenue Growth | ★ 17.21 | N/A |
| 52 Week Low | $29.10 | $0.09 |
| 52 Week High | $44.02 | $83.60 |
Technical Indicators
Market Signals| Indicator | AR | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 55.68 | 54.09 |
| Support Level | $31.15 | $20.81 |
| Resistance Level | $34.90 | $69.00 |
| Average True Range (ATR) | 1.26 | 10.54 |
| MACD | 0.26 | -1.25 |
| Stochastic Oscillator | 78.73 | 23.97 |
Price Performance
Historical ComparisonAbout AR Antero Resources Corporation
Antero Resources, based in Denver, explores for and produces natural gas and natural gas liquids in the United States and Canada. At the end of 2024, the company reported proven reserves of 17.9 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,424 million cubic feet of equivalent a day in 2024 at a ratio of 35% liquids and 65% natural gas.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.